post-add

Articles for Zydus Lifesciences

Zydus Receives Final USFDA Approval For Amantadine Extended-Release Capsules

Additionally, it has received tentative approval for the 137 mg dosage strength

Read More
Zydus Secures COFEPRIS Approval For Mamitra, Trastuzumab Biosimilar To Combat Multiple Cancers

This new approval allows Mamitra to be marketed in strengths of 150 mg and 440 mg, targeting HER2 overexpressing metastatic breast cancer (MBC), HER2 overexpressing early breast cancer (EBC), and advanced gastric cancer

Read More
Bayer Secures Full Ownership Of Bayer Zydus Pharma

Established in 2011 as a 50:50 joint venture for pharmaceutical sales and marketing in India, Bayer has now acquired the remaining 25 per cent stake to secure full ownership of the entity, in accordance with pre-agreed joint venture terms

Read More

Subscribe to our newsletter to get updates on our latest news